Literature DB >> 12419344

Gas chromatographic-mass spectrometric method for the determination of alkylresorcinols in human plasma.

Anna-Maria Linko1, Kirsti Parikka, Kristiina Wähälä, Herman Adlercreutz.   

Abstract

Alkylresorcinols can be found in high amounts in whole grain cereals, especially in rye. Previously it has not been possible to measure alkylresorcinols in plasma. In this paper a validated gas chromatographic-mass spectrometric method for the quantitative determination of alkylresorcinols with chain lengths of C15:0, C17:0, C19:0, C21:0, and C23:0 in human plasma samples is presented. Other alkylresorcinols may be measured with the method as well, but their assay was not validated in this work. In this work also the amount of alkylresorcinol C25:0 was measured. The pretreatment of plasma samples consists of a simple incubation, an extraction with diethyl ether and a chromatographic purification before the GC-MS analysis. As internal standard an alkylresorcinol C20:0 was used. The validation of the method showed that it fulfilled the reliability criteria. Calibration graphs were linear over the range of 4.1-660pg per injection. The mean recovery percentage was 112+/-10.8%. Our results show that the alkylresorcinols are found in plasma in the same ratio, as found in rye grains, according to literature. The alkylresorcinols were in the unconjugated form. The total amounts of alkylresorcinols in two plasma samples analyzed here were 333 and 381nmol/L.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419344     DOI: 10.1016/s0003-2697(02)00226-9

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  9 in total

1.  Comparison of plasma alkylresorcinols (AR) and urinary AR metabolites as biomarkers of compliance in a short-term, whole-grain intervention study.

Authors:  Nicola M McKeown; Matti Marklund; Jiantao Ma; Alastair B Ross; Alice H Lichtenstein; Kara A Livingston; Paul F Jacques; Helen M Rasmussen; Jeffrey B Blumberg; C-Y Oliver Chen
Journal:  Eur J Nutr       Date:  2015-06-05       Impact factor: 5.614

Review 2.  Biological activity of phenolic lipids.

Authors:  Maria Stasiuk; A Kozubek
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

3.  Plasma alkylresorcinols as a biomarker of whole-grain food consumption in a large population: results from the WHOLEheart Intervention Study.

Authors:  Alastair B Ross; Alexandre Bourgeois; Harrison Ndung'u Macharia; Sunil Kochhar; Susan A Jebb; Iain A Brownlee; Chris J Seal
Journal:  Am J Clin Nutr       Date:  2011-12-14       Impact factor: 7.045

4.  Alkylresorcinols in adipose tissue biopsies as biomarkers of whole-grain intake: an exploratory study of responsiveness to advised intake over 12 weeks.

Authors:  H Wu; M Kolehmainen; H Mykkänen; K Poutanen; M Uusitupa; U Schwab; A Wolk; R Landberg
Journal:  Eur J Clin Nutr       Date:  2015-09-02       Impact factor: 4.016

5.  Present status and perspectives on the use of alkylresorcinols as biomarkers of wholegrain wheat and rye intake.

Authors:  Alastair B Ross
Journal:  J Nutr Metab       Date:  2012-01-18

6.  An expedient synthesis of 5-n-alkylresorcinols and novel 5-n-alkylresorcinol haptens.

Authors:  Kirsti Parikka; Kristiina Wähälä
Journal:  Beilstein J Org Chem       Date:  2009-05-19       Impact factor: 2.883

7.  Phenolic lipids affect the activity and conformation of acetylcholinesterase from Electrophorus electricus (Electric eel).

Authors:  Maria Stasiuk; Alicja Janiszewska; Arkadiusz Kozubek
Journal:  Nutrients       Date:  2014-04-30       Impact factor: 5.717

Review 8.  An Overview of Alkylresorcinols Biological Properties and Effects.

Authors:  Anastasia A Zabolotneva; Olga P Shatova; Anastasia A Sadova; Aleksandr V Shestopalov; Sergei A Roumiantsev
Journal:  J Nutr Metab       Date:  2022-01-05

9.  Responsiveness of urinary and plasma alkylresorcinol metabolites to rye intake in finnish women.

Authors:  Mylène Aubertin-Leheudre; Anja Koskela; Adile Samaletdin; Herman Adlercreutz
Journal:  Cancers (Basel)       Date:  2010-04-14       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.